CytRx Corp. buy melinda
Start price
19.05.17
/
50%
€3.03
Target price
25.05.17
€4.80
Performance (%)
23.59%
End price
25.05.17
€3.74
Summary
This prediction ended on 25.05.17 with a price of €3.74. The BUY prediction by melinda finished with a performance of 23.59%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| CytRx Corp. | - | - | - | - |
| iShares Core DAX® | 0.855% | 1.375% | 2.609% | 52.294% |
| iShares Nasdaq 100 | -0.989% | -3.844% | 25.552% | 78.877% |
| iShares Nikkei 225® | -1.781% | -8.530% | 42.813% | 65.506% |
| iShares S&P 500 | 0.057% | 0.610% | 21.574% | 63.546% |
Comments by melinda for this prediction
In the thread CytRx Corp. diskutieren
Die Registrierung für Phase 2 abgeschlossen ist . Diskussion des Poster auf der ASCO am 3. Juni 2017. Phase - 3 - Test für das dritte Quartal 2017 geplant.